Latest News
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
GLOBUS MEDICAL (NYSE:GMED) is a strong growth stock with reasonable valuation, solid profitability, and a healthy balance sheet, making it an attractive option for investors seeking growth at a fair price.
Via Chartmill · June 7, 2025
Via The Motley Fool · June 7, 2025
VIPSHOP HOLDINGS (NYSE:VIPS) offers growth at a reasonable price, with strong profitability, low debt, and a PEG of 0.36. A potential GARP pick for long-term investors.
Via Chartmill · June 7, 2025
Coupang is executing its way to become the Amazon of South Korea.
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
CATALYST PHARMACEUTICALS (CPRX) offers strong growth, solid profitability, and an attractive valuation, making it a standout in biotech.
Via Chartmill · June 7, 2025
Via The Motley Fool · June 7, 2025
META PLATFORMS (NASDAQ:META) meets key quality investing criteria with strong growth, high ROIC, and solid financials, making it a stock worth considering for long-term investors.
Via Chartmill · June 7, 2025
Each of the index's highest-yielding names has its own unique story right now.
Via The Motley Fool · June 7, 2025